NICE backs Roche’s Gazyvaro for follicular lymphoma

26th July 2017 Uncategorised 0

The National Institute for Health and Care Excellence has issued final draft guidance recommending that use of Roche’s Gazyvaro to treat follicular lymphoma be funded for NHS use via the Cancer Drug Fund.

More: NICE backs Roche’s Gazyvaro for follicular lymphoma
Source: News